Repository logo
 
Publication

Using cancer registries to supplement clinical trial data and inform regulatory decision

dc.contributor.authorCosta, Filipa Alves da
dc.contributor.authorMiranda, Ana da Costa
dc.date.accessioned2021-05-25T13:35:43Z
dc.date.available2021-05-25T13:35:43Z
dc.date.issued2020-10
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationda Costa, FA, da Costa Miranda, A. Using cancer registries to supplement clinical trial data and inform regulatory decision. Pharmacoepidemiol Drug Saf. 2020; 29: 1319– 1321. https://doi.org/10.1002/pds.4931pt_PT
dc.identifier.doi10.1002/pds.4931pt_PT
dc.identifier.issn1053-8569
dc.identifier.issn1099-1557
dc.identifier.urihttp://hdl.handle.net/10400.26/36597
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherWileypt_PT
dc.relation.publisherversionhttps://doi.org/10.1002/pds.4931pt_PT
dc.subjectCancerpt_PT
dc.subjectClinical trialpt_PT
dc.titleUsing cancer registries to supplement clinical trial data and inform regulatory decisionpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1321pt_PT
oaire.citation.startPage1319pt_PT
oaire.citation.titlePharmacoepidemiology and Drug Safetypt_PT
oaire.citation.volume29(10)pt_PT
rcaap.embargofctPolítica de copyright do editorpt_PT
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Costa and Miranda 2019_Using cancer registries to supplement clinical trial data an inform regulatory decision.pdf
Size:
125.11 KB
Format:
Adobe Portable Document Format